Salah Ghabri

Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.

Elisabeth Fenwick, Lotte Steuten, Saskia Knies, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.

Elisabeth Fenwick, Lotte Steuten, Saskia Knies, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Trusting the Results of Model-Based Economic Analyses: Is there a Pragmatic Validation Solution?

Salah Ghabri, Matt Stevenson, Jörgen Möller, 2018, PharmacoEconomics.

Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment Guidelines

Salah Ghabri, Jean-Michel Josselin, Irina Cleemput, 2018, PharmacoEconomics.

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

Salah Ghabri, Els Torreele, Sara Ghorashian, 2009, The Lancet.

Health-state utility estimates for health technology assessment: a review of the manufacturers’ submissions to the French National Authority for Health

Salah Ghabri, C. Le Galès, F. Hamers, 2017, Expert review of pharmacoeconomics & outcomes research.

In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness

Salah Ghabri, Johannes Blum, S. Blesson, 2012, PLoS neglected tropical diseases.